Active substance

Results for the substance darolutamide

1 result

About this active substance

Darolutamide is an antiandrogen used for the treatment of non-metastatic castration-resistant prostate cancer. It works by blocking androgen receptors, thereby inhibiting the growth of androgen-dependent cancer cells.

The medication is taken orally, usually twice daily, with the dose adjusted based on the patient's response and tolerability. Common side effects include fatigue, joint pain, skin rashes, and increased blood pressure.

Darolutamide is contraindicated in patients with hypersensitivity to the active substance or any of its excipients. Its use also requires careful monitoring to prevent severe adverse reactions.

This medication is an important option for patients with advanced prostate cancer, helping to slow disease progression and improve their quality of life.